Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Inflammation; Myocarditis; Sarcoidosis Phase 2 ClinicalTrials
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Lung Neoplasms; Mesothelioma; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Brain Neoplasms Phase 1 ClinicalTrials
CONTENTS